Search results
Results from the WOW.Com Content Network
Born: 1948 (age 76–77) Education: Miami University George Washington University (): Known for: Schizophrenia research NIMH CATIE study [1]: Children: 2: Awards: Lieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders
(Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. The ...
But instead of arresting her, the officer called her parents, who admitted her to the New York Psychiatric Institute. This time, she got a referral to an early intervention program called OnTrackNY. First, a staffer established that Mar J was under 30 and that her first psychotic break had happened within the last two years.
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...
In the previous study, luvadaxistat failed to meet the main goal of change from baseline in negative symptoms of schizophrenia, however, it met the secondary goal of improving cognitive performance.
He is the original author of the landmark neurodevelopmental hypothesis of schizophrenia (first published in The Neurology of Schizophrenia, Elsevier, 1986) [12] and in the more cited reference, Arch Gen Psychiatry 1987, (the most cited publication [>4100 citations] about the biology of schizophrenia in Google Scholar).
National Alliance for Research on Schizophrenia & Depression The Brain & Behavior Research Foundation ( BBRF ) is a nonprofit 501(c)(3) organization that funds mental health research. It was originally called the National Alliance for Research on Schizophrenia & Depression, or NARSAD.
Main Menu. News. News